A Study of Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration
Clinical trial NCT03387566 · COMPLETED
Trial details
- NCT number
- NCT03387566
- Sponsor
- Huabo Biopharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2020-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.